Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are in clinical trials. As a result, the drug did not face much competition and has taken over the global market, with its array of application constantly expanding. The substantial and high-level evidence gathered over the years support the use of Clopidogrel for reduction of mortality and morbidity patients with acute coronary syndrome, myocardial infarction, and a number of other indications. As a result, the drug has developed a formidable presence in the global market over the years. Moreover, the drug’s relative ease of use, low rate of incidence of adverse reactions, and good tolerability have made it the de-facto antiplatelet agent for the reduction of atherosclerotic events in patients.These factors have helped the global Clopidogrel market to tread along an excellent growth path in the past few years and the market is expected to embark upon a healthy growth path in the next few years as well. However, the overall profitability of the market has reduced to a certain extent owing to entry of a number of generic products post the patent expiry of Clopidogrel manufacture in 2013. Nevertheless, the vast pool of patients prescribed Clopidogrel on an annual basis across the globe will allow market players excellent growth prospects in the next few years.
The report details the trend, potential and market size of Clopidogrel market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Clopidogrelmarket, defines the market attractiveness level of Clopidogrel market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Clopidogrel industry, describes the types of Clopidogrel market, the applications of major players and the market size, and deeply analyzes the current situation of the global Clopidogrel market and the development prospects and opportunities of Clopidogrel industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Clopidogrel market in Chapter 13.
By Player:
Sanofi (France)
Lepu Medical Technology (China)
Shenzhen Salubris Pharmaceuticals (China)
By Type:
25mg
75 mg
300 mg
By End-User:
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Clopidogrel Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Clopidogrel Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Clopidogrel Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Clopidogrel Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Clopidogrel Market Analysis and Outlook to 2022
-
7.1 Global Clopidogrel Consumption (2017-2022)
-
7.2 United States Clopidogrel Consumption (2017-2022)
-
7.3 Europe Clopidogrel Consumption (2017-2022)
-
7.4 China Clopidogrel Consumption (2017-2022)
-
7.5 Japan Clopidogrel Consumption (2017-2022)
-
7.6 India Clopidogrel Consumption (2017-2022)
-
7.7 South Korea Clopidogrel Consumption (2017-2022)
8 Region and Country-wise Clopidogrel Market Analysis and Outlook to 2028
-
8.1 Global Clopidogrel Consumption Forecast (2022-2028)
-
8.2 United States Clopidogrel Consumption Forecast (2022-2028)
-
8.3 Europe Clopidogrel Consumption Forecast (2022-2028)
-
8.4 China Clopidogrel Consumption Forecast (2022-2028)
-
8.5 Japan Clopidogrel Consumption Forecast (2022-2028)
-
8.6 India Clopidogrel Consumption Forecast (2022-2028)
-
8.7 South Korea Clopidogrel Consumption Forecast (2022-2028)
9 Global Clopidogrel Market Outlook by Types and Applications to 2022
-
9.1 Global Clopidogrel Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 25mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 75 mg Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 300 mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Clopidogrel Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Private Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Clopidogrel Market Outlook by Types and Applications to 2028
-
10.1 Global Clopidogrel Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 25mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 75 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 300 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Clopidogrel Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Private Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Clopidogrel Import and Export Analysis (Top 5 Countries)
-
11.1 Global Clopidogrel Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Clopidogrel Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Clopidogrel Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Clopidogrel Market Competitive Analysis
-
14.1 Sanofi (France)
-
14.1.1 Sanofi (France) Company Details
-
14.1.2 Sanofi (France) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi (France) Clopidogrel Product and Service
-
14.2 Lepu Medical Technology (China)
-
14.2.1 Lepu Medical Technology (China) Company Details
-
14.2.2 Lepu Medical Technology (China) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Lepu Medical Technology (China) Clopidogrel Product and Service
-
14.3 Shenzhen Salubris Pharmaceuticals (China)
-
14.3.1 Shenzhen Salubris Pharmaceuticals (China) Company Details
-
14.3.2 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Clopidogrel
-
Figure Clopidogrel Picture
-
Table Global Clopidogrel Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Clopidogrel Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Clopidogrel Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Clopidogrel Consumption by Country (2017-2022)
-
Figure United States Clopidogrel Consumption and Growth Rate (2017-2022)
-
Table Europe Clopidogrel Consumption and Growth Rate (2017-2022)
-
Figure China Clopidogrel Consumption and Growth Rate (2017-2022)
-
Figure Japan Clopidogrel Consumption and Growth Rate (2017-2022)
-
Figure India Clopidogrel Consumption and Growth Rate (2017-2022)
-
Figure South Korea Clopidogrel Consumption and Growth Rate (2017-2022)
-
Figure Global Clopidogrel Consumption Forecast by Country (2022-2028)
-
Figure United States Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Clopidogrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 25mg Consumption and Growth Rate (2017-2022)
-
Figure Global 75 mg Consumption and Growth Rate (2017-2022)
-
Figure Global 300 mg Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Private Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global 25mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 75 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 300 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Private Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Clopidogrel Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Clopidogrel Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (France) (Foundation Year, Company Profile and etc.)
-
Table Sanofi (France) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi (France) Clopidogrel Product and Service
-
Table Lepu Medical Technology (China) (Foundation Year, Company Profile and etc.)
-
Table Lepu Medical Technology (China) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lepu Medical Technology (China) Clopidogrel Product and Service
-
Table Shenzhen Salubris Pharmaceuticals (China) (Foundation Year, Company Profile and etc.)
-
Table Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Product and Service
-
